CBD Forum by Chow420

Go back
Refer
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Elon Musk Says He’s ‘Almost Always’ Sober During Late-Night Posting Sessions

Elon Musk says that he benefits from the use of ketamine –– and investors should be pleased that he takes it –– but when he posts late at night on the social media platform he owns, he insists that he is rarely under the influence. The Tesla CEO made all of those comments during a well-publicized interview with the journalist Don Lemon. “There are times when I have sort of a … negative chemical state in my brain, like depression I guess, or depression that’s not linked to any negative news, and ketamine is helpful for getting one out of the negative frame of mind,” Musk told Lemon, as quoted by CNN.com.  Per CNN, “Musk added that he has a prescription for the drug from ‘an actual, real doctor’ and uses ‘a small amount once every other week or something like that.’” Musk’s drug use has been the subject of intense speculation and media coverage for years. The Wall Street Journal reported last year that Musk is known to use ketamine. “Routine drug use has moved from an after-hours activity squarely into corporate culture, leaving boards and business leaders to wrestle with their responsibilities for a workforce that frequently uses. At the vanguard are tech executives and employees who see psychedelics and similar substances, among them psilocybin, ketamine and LSD, as gateways to business breakthroughs,” the Journal reported, noting that the “account of Musk’s drug use comes from people who witnessed him use ketamine and others with direct knowledge of his use.” Following the publication of that story, Musk posted an endorsement of ketamine’s benefits. “Depression is overdiagnosed in the US, but for some people it really is a brain chemistry issue,” Musk said at the time. “But zombifying people with SSRIs for sure happens way too much. From what I’ve seen with friends, ketamine taken occasionally is a better option.” The Wall Street Journal also reported earlier this year on Musk’s drug use, noting that it apparently spooked some executives at his SpaceX. That prompted NASA to issue a statement clearing the company of any illicit activity. “The agency does not have evidence of non-compliance from SpaceX on how the company addresses the drug- and alcohol-free workforce regulations,” NASA said in a statement at the time. “We expect our commercial partners to meet all workplace safety requirements in the execution of those missions and the services they provide the American people.” In his interview with Lemon, Musk said that his use of ketamine should not concern investors. “From a standpoint of Wall Street, what matters is execution,” Musk said, as quoted by CNN. “Are you building value for investors? Tesla is worth about as much as the rest of the car industry combined … so from an investor standpoint, if there is something I’m taking, I should keep taking it.” More from CNN’s report on the interview: “While Musk said he doesn’t drink and doesn’t ‘know how to smoke pot,’ he didn’t specify whether he was talking about ketamine or another substance when he said he is ‘almost always’ sober while posting late at night…Musk also discussed the state of the core advertising business on X, which has suffered since the billionaire acquired the company formerly known as Twitter because of a rise in hateful and controversial content on the platform. Musk previously said advertisers who left X over concerns about antisemitic content could ‘go f**k yourself’ and accused them of killing the company.” Musk’s interview with Lemon has drawn considerable attention this week for its contentious exchanges. The tension spilled over and apparently prompted Musk to cancel a planned deal with Lemon, the former CNN host, to host a new show on the social media platform X. “Elon publicly encouraged me to join X with a new show, saying I would have his ‘full support,’” Lemon said in a statement last week. He added that Musk’s “commitment to a global town square where all questions can be asked and all ideas can be shared seems not to include questions of him from people like me.” At one point in the interview, Lemon asked Musk about the uptick in hate speech on the platform, formerly known as Twitter, since Musk took it over a year ago. “I don’t have to answer questions from reporters, Don,” Musk said in response, as quoted by CNN. “The only reason I’m doing this interview is because you’re on the X platform and you asked for it. Otherwise, I would not do this interview.” In a statement of its own, X said, “The Don Lemon Show is welcome to publish its content on X, without censorship, as we believe in providing a platform for creators to scale their work and connect with new communities. However, like any enterprise, we reserve the right to make decisions about our business partnerships, and after careful consideration, X decided not to enter into a commercial partnership with the show.”

https://hightimes.com/

Proposed Tennessee Rules Seek To Close Hemp THCA Loophole

Proposed rules to regulate hemp in Tennessee could put a limit on the total amount of all forms of THC allowed in products, potentially closing what some see as a legal loophole that has led to the marketing of hemp flower high in THCA. When smoked, THCA converts to delta-9 THC, the cannabinoid primarily responsible for the psychoactive effects of weed. In April 2023, Tennessee lawmakers passed legislation to regulate and tax hemp products grown, manufactured and sold in the state. Under the bill, the Tennessee Department of Agriculture was tasked with developing rules to govern the industry, including regulations for product testing, compliance and enforcement. In December, the department released a draft proposal of the new rules mandated by the legislation. The 2018 Farm Bill legalized hemp at the federal level, defining hemp as cannabis that contains no more than 0.3% delta-9 THC. Using this definition, many hemp growers have begun producing cannabis that is high in THCA, a cannabinoid that is converted to delta-9 THC when subjected to heat through a process known as decarboxylation.  Federal regulations require hemp to be tested for THC content within 30 days of harvest, using a test that combines the amounts of delta-9 THC and THCA using a specific formula to determine total THC. Cannabis with more than 0.3% total THC at testing time is considered marijuana under federal law and is still illegal. Some hemp growers, however, have developed agricultural processes and strains of cannabis that do not express high levels of THCA until late in the 30-day testing window. By testing early in the window, growers can produce hemp flower that complies with regulations at testing time but has high levels of THCA after harvesting and packaging. As a result, THCA hemp flower is available in many states that have not legalized cannabis, despite the fact that it is psychoactive when smoked or vaped. The companies marketing these products argue that they comply with the Farm Bill and thus are legal. Others, however, see this interpretation as a loophole that is likely to be closed. Already, several states have taken steps to regulate hemp cannabinoids. “There is a very cat’s-out-of-the-bag mentality around it. Some people view this as the actual legalization of cannabis in America,” Madeline Scanlon, cannabis insights manager at market data analyst firm Brightfield Group, told MJBizDaily. “Other people view this as a loophole to be squashed and are advocating for it. But no matter, it’s out there,” Scanlon added. “People can buy it just like they would normal cannabis.” The new rules proposed by the Tennessee Department of Agriculture would redefine hemp by requiring finished products to have no more than 0.3% total THC. Hemp advocates say the rule would make many THCA, delta-8 THC and CBD products that are available now illegal, with devasting effects on the state’s hemp growers and retailers. “Unfortunately, they are regulating it out of business,” Kelley Hess, executive director of the Tennessee Growers Coalition, told the Chattanooga Times Free Press in January. “They are creating law in the rules and are exceeding their authority in creating a new definition of hemp in the rules outside of the law.” The Department of Agriculture’s proposed rules would also allow it to conduct random inspections and test products being sold by retailers. Hemp advocates argue that by the time the products have been manufactured and received by retailers, some THCA may have decarboxylated, making them contain more than 0.3% delta-9. Hess says that the rule would “wipe out” the industry for THCA and CBD flower in Tennessee. “There is practically no way that a farmer or grower could meet all the rigorous standards on the growing side in addition to all of the standards they have put on for their products to be put on the shelf,” Hess said. The Department of Agriculture held a public hearing on the proposed rules in February. According to the Tennessee Growers Coalition, between 200 and 300 hemp industry supporters attended the hearing to express their views on the draft rules. Andy Chesney, owner of the Hemp House in West Knoxville, testified before regulators at the hearing. “By eliminating THC, you’re not really gaining the full effects of the plant, or the full benefits of it,” Chesney said. “And so from a consumer perspective, the frustrating part is that what seems to be considered by the powers that be in Tennessee, is this getting high and regulating people who are attempting to get high.” Kim Doddridge, public information officer for the Tennessee Department of Agriculture, said after the hearing that the agency is currently reviewing the public comments and developing the final rules. She also noted that the law requires the department to finalize the new rules by July 1. “The record, responses, and final rule coming from the February 6 hearing will be submitted to the TN Attorney General’s Office,” Doddridge said, according to a report from local media. “Their office will review the final rule for legality and constitutionality, and if approved, the final rule will be filed with the Secretary of State’s Office and will be effective 90 days later.”

https://hightimes.com/

African County of Eswatini Introduces Medical Cannabis Legislation

The landlocked country of Eswatini (formerly known as Swaziland), located in southern Africa, recently made a move to legalize medical cannabis. According to a report from VOA Zimbabwe, King Mswati III and the Eswatini government have introduced medical cannabis legislation hoping that it will help curb illegal sales and allow the country to benefit from tax revenue. “The legislation will also provide measures to guard against increasing the black market,” said spokesperson Alpheous Nxumalo. “This has robbed government taxes, Eswatini, an opportunity to grow their economy and robbed even the farmers themselves who have been trying to make a living using this cannabis. We look forward to the unbanning of the cannabis plant as an opportunity to develop the country, our economy and to empower Eswatini themselves.” Currently only one company, Profile Solutions, has been approved to be a legal cannabis cultivator in Eswatini. If medical cannabis is legalized in the country, it would amend a statue that was implemented by the British in 1922 through the Opium and Habit-forming Drugs Act. British control over Eswatini lasted from 1903-1968, but the country’s name of Swaziland wasn’t changed to its current name until 2018. VOA Zimbabwe obtained a statement from Dr. Thys Louren, a medical practitioner with Occupational Health Eswatini, who believes that medical cannabis legalization would provide a multitude of benefits for the country. “I stand here urging for the transformative change of Eswatini’s health care landscape toward a healthier and more sustainable Eswatini,” Louren said. “It is not just a medical decision but a holistic solution for our patients, community and economy.” The news outlet also spoke with Business Eswatini CEO E. Nathi Dlamini, who explained the necessity of bringing Eswatini up to speed with the global medical cannabis industry. “Many countries are well ahead in this regard in terms of developing industries to support investment, create jobs which by the way, we desperately need,” Dlamini said. “As Business Eswatini, we are very thankful that from the highest authority of the land now, we are beginning to be one-minded on this.” Additionally, residents such as merchant Maqhawe Tsabedze admitted that he’s put his kids through school while thriving from illegal cannabis businesses. “The decriminalization of cannabis will help a lot and will perhaps stop police from raiding and confiscating our products, which we make a living from selling,” Tsavedze said. “Rain or sunshine, we make sure we put bread on the table so that our children do not go to bed on empty stomachs. Since there are no jobs, we make a living from selling cannabis on the streets.” The medical cannabis legalization proposal has only been introduced, and requires a three-fourths vote in both the House of Assembly and Senate before it can be passed into law. Previous attempts to get medical cannabis legalized in Eswatini have fallen short. One version was tabled by the Eswatini Ministry of Health in 2020, and resurfaced in May 2023, according to a report from Semafor Africa. The news outlet spoke with the Eswatini Cannabis Association (ESA) at the time, who explained that the proposed bill would establish a Medicines Regulatory Authority to “import, export, and trade in, by wholesale, cannabis and cannabis products.” “They cannot be both the referee and the player at the same time,” said ESA chair Saladin Magagula at the time. “You cannot as an authority give yourself an export and import license while also issuing the same to people.” However, farmers who rely on illegally cultivating for their livelihood voiced concerns about legalization. “Lomtsetfo [the law’ might make things worse because the rich companies will become our competition,” said an anonymous farmer. Eswatini is home to more than 1 million people, and a large percentage of which suffer from HIV/AIDS. In 2021, The Guardian covered how older women were illegally cultivating cannabis (called “Swazi Gold”) to help both their families as well as children who were orphaned as a result of the HIV/AIDS epidemic. “Poverty led me into this business,” one woman said. “There are no jobs. These children need to go to school but there is no help at all from government. I have to commit crime, farming weed, to ensure I take care of them. I had three children but they all passed away, leaving me with five grandchildren to care for. All my children were HIV positive and they died because of that. I also take care of two other children, relatives to my late husband, whose parents are also dead.” The country was also the feature of a documentary by Strain Hunters in April 2013, which explored both the cannabis industry as well as genetics unique to the region. Other countries in Africa have begun to embrace cannabis. Medical cannabis sales were approved back in July 2022 in Zimbabwe. Last November, the South African National Assembly approved a cannabis bill that decriminalized cannabis, but did not legalize sales. It does, however, allow residents to cultivate their own plants for personal use.

https://hightimes.com/

Inhalable Lung Cancer Drug Delivery Performs Well, Study Suggests

In a twist of irony, a powerful drug that battles lung cancer might be delivered safer via inhalation versus surgery, injection, and other invasive methods, a new study suggests. Researchers associated with Columbia University observed rat models and determined that a new inhalable lung cancer treatment is capable of delivering localized immunotherapy to difficult-to-treat tumors. Lately researchers have been looking for a safe and non-invasive alternative to current approaches to tackling cancerous tumors that require direct injection of immunomodulators into the tumors. But when cancer is found in the lungs, it is typically hard to reach and treat with drugs by direct injection. Researchers believe that a potent drug that fights cancer might be better delivered via inhalation in order to battle lung cancer. The study was published recently in Nature Nanotechnology and online Jan. 11, showing how nanobubbles containing a powerful drug could be administered via inhalation to provide a safer delivery route.  Medscape reports that researchers demonstrated that nanobubbles can deliver potent immunotherapy directly to tough-to-treat lung cancer tumors via inhalation. Researchers suspect that exosomes, also known as extracellular vesicles (EVs), could be the key to the next step in lung cancer treatment. “Exosomes work like text messages between cells , sending and receiving information,” said lead researcher Ke Cheng, PhD, professor of biomedical engineering at Columbia, who has been working with stem cells and exosomes for over 15 years. “The significance of this study is that exosomes can bring mRNA-based treatment to lung cancer cells locally, unlike systemic chemotherapy that can have side effects throughout the body. And inhalation is totally noninvasive. You don’t need a nurse to use an IV needle to pierce your skin.” The study could help move research forward by allowing for the therapeutic uses of exosomes, inhalable treatments for lung conditions, and the safe delivery of powerful interleukin-12 (IL-12) immunotherapy. Researchers have known about IL-12’s abilities to fight cancer for decades, but early human trials lead to serious side effects and several deaths. Researchers are now trying new delivery methods that target tumor cells without affecting healthy tissue. The research team’s new approach involves inserting mRNA for IL-12 into exosomes. “One of the advantages of exosomes is that they are naturally secreted by the body or cultured cells,” he noted. “They have low toxicity and have multiple ways of getting their message into cells.” The scientists borrowed an approach that captured public attention during the pandemic: Using messenger RNA, which directs cells to make proteins for tasks — including boosting immune response. In the study, researchers developed inhalable extracellular vesicles loaded with IL-12 mRNA to battle lung cancer and bolster systemic immunity in mice with tumors. IL-12 mRNA was loaded into human embryonic kidney cell-derived exosomes (HEK-Exo) through electroporation, yielding IL-12 mRNA-loaded exosomes (IL-12-Exo).  When inhaled by mice with lung tumors, IL-12-Exo outperformed IL-12 mRNA-loaded liposomes (IL-12-Lipo)n and minimized systemic toxicity. These inhaled IL-12-Exo promoted immune activation, systemic immunity, and immune memory, culminating in lung tumor suppression and heightened resistance against tumor recurrences. Human trials could launch within five years, and help put an end to the devastation that lung cancer causes each year.  Lung cancer is the leading cause of cancer death overall and among both men and women. (The second leading cause of cancer death is prostate for men and breast for women.) In 2021, 134,592 people died from lung cancer, or 22% of all cancer deaths. In the United States, cigarette smoking is linked to about 80% to 90% of lung cancer deaths.  However, even the Lung Cancer Society notes that while it is not risk-free as it involves combustion, cannabis smoke is not as carcinogenic as tobacco smoke. NORML explains this very well: THC and CBD, the two most popular cannabis active ingredients, are non-carcinogenic and demonstrate anticancer properties in vivo and in vitro. Nicotine—in stark contrast—promotes the development of cancer cells and their blood supply. In addition, cannabinoids stimulate other biological activities and responses that may mitigate the carcinogenic effects of smoke. People who smoke cigarettes are 15 to 30 times more likely to develop lung cancer or die from lung cancer than people who do not smoke. Even smoking a few cigarettes a day or on occasion increases the risk of lung cancer. Even if you don’t smoke anything, or only vape, you’re still not off the hook, depending on how hazardous areas are that you live in. People also get lung cancer from radon, and they usually have no control over the undetectable radioactive gas caused by the natural decay of traces in uranium in rocks and the soil. The U.S. Environmental Protection Agency (EPA)  estimates that radon causes about 21,000 lung cancer deaths each year. 

https://hightimes.com/

Morocco Reports First Legal Cannabis Cultivation Numbers, 294 Tons in 2023

While recreational cannabis may still be illegal in the North African country of Morocco, the nation is kicking off a new era of legal cannabis cultivation and export. As the third month of 2024 comes to a close, the country has shared data about its first legal harvest season in 2023. According to Morocco’s cannabis regulators, National Agency for the Regulation of Cannabis-Related Activities (ANRAC), the country’s first legal harvest in 2023 was 294 metric tons. It involved 32 cooperatives comprising 430 farms spanning 277 hectares in the northern Rif Mountains of Al Houceima, Taounat and Chefchaouen, according to ANRAC. First reported by Reuters, the United Nations drugs agency also noted that approximately 47 hectares of the Rif Mountains are dedicated to cannabis output. However, that’s only about a third of the amount Morocco had in 2003 due to government crackdowns on illicit operations.  The region has long been used for cannabis cultivation, where farmers have long used the crop to support their villages. The country legalized cannabis cultivation for medical and industrial use in 2021, with the government citing opportunities to boost revenue, create jobs and protect the environment as Morocco pressed forward with the new chapter. The country has been a long-time producer of illicit hashish, but with the highly anticipated opening of the European cannabis market, the hope is that it will soon be a key supplier to its northern neighbor’s blossoming industry. ANRAC was then created in 2022, made to oversee the entire cannabis system involving growers, cultivators and processors while authorizing and certifying all cannabis cultivation and exportation activities. Morocco’s first growing season began in June 2023. According to a Morocco World News report, importing seeds for cultivation generally begins in April, though indigenous varieties like the Moroccan landrace Beldia are sown in February — a testament to the country’s commitment to preserving its cannabis history while still catering to the emerging legal market. The outlet also noted that Morocco granted 609 authorizations last year in its ongoing effort to formalize the new sector, alongside the certification of 2.1 million cannabis seeds in 2023. Currently, two legal cannabis transformation units are operating with two others waiting for equipment. According to ANRAC, 15 cannabis products are currently in the process of being authorized for medical use. Thinking beyond its own borders, Morocco also awarded 54 export permits in 2023. Moving ahead, ANRAC is examining applications by 1,500 farmers organized into 130 cooperatives, and cultivation for Beldia has already begun. Cultivation for recreational use is still illegal, though it’s generally tolerated — especially in northern Morocco, where cannabis cultivation has stood as one of the primary economic activities in the region. The legislation was created with this history in mind, in an attempt to improve the incomes of farmers while protecting them from drug traffickers who widely dominate the illicit trade and export of cannabis. While some farmers have embraced the change, others are more resistant and remain loyal to the members of the illicit drug trade who helped them to retain a steady income in past years. It reflects a broader resistance to the change in the Rif region, given its rich cannabis-specific history, and it may take longer than just a couple years to get everyone on board. “Cannabis has been in place in the region for centuries, and changing it from one day to the next is going to create resistance,” Khalid Mouna, a professor at Moulay Ismail University who studies Morocco’s cannabis economy, told Bloomberg last year. While there are certain barriers for farmers, like upfront costs, administrative hurdles and challenging quality standards for small businesses and cultivators, Morocco has its fair share of advantages. Hanway Associates Co-Founder Alastair Moore told Bloomberg that Morocco already has an established cannabis reputation, potentially giving its products a built-in “stamp of legitimacy” as they are exported to new markets. Still, experts like Moore argue that it’s unlikely Morocco will reach its full potential so long as cultivation is limited to medical and industrial markets. “The real opportunity for Morocco in the long term is going to be in recreational because that’s where their brand is,” Moore said.

https://hightimes.com/

New Cannabis Lawsuit Filed Against Federal Government

Last year in October, a group of cannabis companies filed a federal lawsuit claiming that a federal ban on cannabis is unconstitutional, but the suit was dismissed in January. On Friday, March 15, a new federal lawsuit was filed in court as Canna Provisions, Inc. et al v. Garland. The case is represented by Boies Schiller Flexner LLP, is pursuing the rights of Verano Holdings Corp, Canna Provisions Inc., Wiseacre Farm Inc., and Gyasi Sellers, who owns a delivery service—all of which operate cannabis businesses in Massachusetts. The plaintiffs claim that the Controlled Substances Act (CSA) has hindered their businesses and prevents them from accessing legal, reliable banking services, and requires that they operate under constant threat of federal prosecution. The new lawsuit claims that the intention behind the CSA was to prevent illegal cannabis from being moved across state lines, but now that so many states have implemented cannabis laws, legislators are no longer trying to enforce that. “Dozens of states have implemented programs to legalize and regulate medical or adult use marijuana,” the lawsuit stated, and continued on to explain that this has led to “safe, regulated, and local access to marijuana” for consumers, while also having “reduced illicit interstate commerce, as customers switch to purchasing state-regulated marijuana over illicit interstate marijuana.” “The ground-shaking shifts in marijuana regulation… together with the nation’s long history of marijuana cultivation and use prior to the CSA, demonstrate the widely-held understanding that Plaintiffs’ marijuana activities implicate a liberty interest that requires protection,” the lawsuit continued. “Today, almost every state permits some form of marijuana that is illegal under federal law, and the majority of the nation’s population lives in states where both medical and adult-use marijuana is legal.” Both the dismissed lawsuit and the newly filed lawsuit hinges on the 2005 court case Gonzales v. Raich in order to demonstrate how the CSA is outdated. “The federal criminal prohibition on intrastate marijuana remains in place, an unjustified vestige of a long-abandoned policy,” the 2023 lawsuit stated. “This unjustified intrusion of federal power harms Plaintiffs, threatens the communities they serve, and lacks any rational purpose.” In January, the U.S. Department of Justice (DOJ) called the original lawsuit a “transparent entreaty.” “Neither Plaintiffs’ contention that they are harmed by other federal laws and policies whose constitutionality is not challenged here, nor Plaintiffs’ allegations that some third parties have independently chosen not to transact with them, suffice to provide Plaintiffs with standing to challenge the CSA,” wrote the DOJ. In response to this, the new lawsuit added text alleging that Congress was trying to prevent interstate cannabis. “Congress was intent on eradicating interstate marijuana, and the factual circumstances that existed in 2005 supported the Government’s position that banning intrastate marijuana was necessary for achieving that goal,” the lawsuit stated. “That legislative and factual landscape no longer exists. It has changed in the proceeding 18 years in ways that even the most ardent advocates of marijuana reform in 2005 would never have imagined possible.” Law 360 spoke with Joshua Schiller of Boies Schiller Flexner LLP, who explained that the newest litigation more directly challenges the Gonzales v. Raich case. He explained that the government has made recent movements contradicting the policy since October 2023. One of the plaintiffs, Verano Holdings Corp, is a multi-state operator. While its business spans multiple states, Schiller explained the importance of its inclusion. “We like having a multistate operator just to show a different business, to show a different story about a different business,” Schiller told Law 360. “And even though it’s a multistate operator, each of its markets are intrastate. They’re not even allowed to bring a seed [across state lines].” The news outlet inquired about why there was no mention of tax code Section 280E, which is a tax policy that prevents deductions and credits from being utilized by “illegal” businesses. “It’s a different case,” Schiller said. “That’s not to say [280E] is not punitive and damaging and therefore unfair. But it’s not the harm we’re seeking to redress. It’s a separate harm that would have to be litigated in a separate case.” The timing of this case aligns with the recent shifts in federal policy. Last August, the U.S. Department of Health and Human Services (HHS) called on the Drug Enforcement Administration (DEA) to reclassify cannabis as a Schedule III substance. NORML Deputy Director Paul Armentano responded to the announcement with hesitance. “It will be very interesting to see how DEA responds to this recommendation, given the agency’s historic opposition to any potential change in cannabis’ categorization under federal law,” said Armentano. “Further, for decades, the agency has utilized its own five-factor criteria for assessing cannabis’ placement in the CSA—criteria that as recently as 2016, the agency claimed that cannabis failed to meet. Since the agency has final say over any rescheduling decision, it is safe to say that this process still remains far from over.” It’s been approximately seven months since that HHS recommendation. Although there hasn’t been any updates from the DEA regarding the recommendation, Vice President Kamala Harris recently held a roundtable conversation about cannabis reform, alongside rapper Fat Joe, Kentucky Gov. Andy Beshear, and more. “I cannot emphasize enough that they need to get to it as quickly as possible, and we need to have a resolution based on their findings and their assessment,” Harris said.

https://hightimes.com/

Study Finds Natural Mushroom Extract Has Better Therapeutic Effects Than Synthesized Psilocybin

A new study shows that natural mushroom extracts may be more therapeutically effective than synthesized psilocybin, which is widely used in research investigating the medicinal potential of the psychedelic drug. The findings suggest that natural mushroom extracts may offer more potential applications for the treatment of serious mental health conditions such as depression, post-traumatic stress disorder (PTSD) and schizophrenia. The study, which was conducted by an interdisciplinary team of researchers from the Hebrew University of Jerusalem’s Hadassah Medical Center BrainLabs Center for Psychedelic Research, compared the effects of the natural and synthesized versions of psilocybin, the compound primarily responsible for the psychoactive effects of magic mushrooms. “My colleagues and I are very interested in the potential of psychedelics to treat serious, treatment resistant psychiatric disorders such as depression, PTSD, OCD and even schizophrenia,” study author Bernard Lerer, a professor of psychiatry and director of the Hadassah BrainLabs Center for Psychedelic Research at Hebrew University, told PsyPost. “There are many anecdotal and clinical reports which suggest that extract of psilocybin-containing mushrooms may have unique effects that are qualitatively and quantitatively different from chemical psilocybin, and also some preclinical studies,” Lerer continued. “This observation has important clinical implications and we wanted to test it empirically in a laboratory study.” Mushrooms that contain psilocybin also produce many other psychoactive and non-psychoactive compounds that may work together to provide enhanced therapeutic effects through a phenomenon known as the entourage effect. However, most clinical research into psilocybin is conducted with synthesized forms of the drug that do not contain these additional potentially therapeutic compounds.  “In Western medicine, there has historically been a preference for isolating active compounds rather than utilizing extracts, primarily for the sake of gaining better control over dosages and anticipating known effects during treatment,” the researchers said in an emailed statement about the study. “The challenge with working with extracts lay in the inability, in the past, to consistently produce the exact product with a consistent compound profile.” “Contrastingly, ancient medicinal practices, particularly those attributing therapeutic benefits to psychedelic medicine, embraced the use of extracts or entire products, such as consuming the entire mushroom,” they continued. “Although Western medicine has long recognized the ‘entourage’ effect associated with whole extracts, the significance of this approach has gained recent prominence.” To conduct the study, the researchers compared the effects of a natural mushroom extract with those of synthesized psilocybin in laboratory mice. The mice were divided into three groups that received either the extract, synthesized psilocybin or a saline solution control. Both forms of psilocybin were given in amounts determined to be therapeutically relevant based on equivalent dosing models between humans and laboratory mice. The researchers assessed the behavioral effects and potential neuroplasticity induced by psilocybin using the head twitch response assay, a commonly employed method of studying the effects of psychedelics in mice. They also compared the metabolic changes in the frontal cortex following treatment and analyzed the expression of synaptic proteins in the brain that can be used as indicators of neuroplasticity. The research showed that the mushroom extract demonstrated a stronger and more prolonged impact on synaptic plasticity, which could indicate the extract offers unique therapeutic benefits. Additionally, the metabolic analyses showed distinct metabolic profiles between synthesized psilocybin and the extract, suggesting that the mushroom extract may have a “unique influence on oxidative stress and energy production pathways,” according to a report from Neuroscience News. While the research showed that the mushroom extract and synthesized psilocybin had different metabolic and neuroplasticity effects, both induced the head twitch response. The findings suggest that the acute effects of both compounds are similar at the basic behavioral level. “We were surprised by the fact that there were no differences in the acute effect on the head twitch response between chemical psilocybin and psilocybin-containing mushroom extract while the differences emerged in terms of longer term effects on synaptic proteins and metabolomics,” Lerer said. “This has important potential clinical relevance.” The researchers noted that while the mushroom extract showed potentially enhanced therapeutic effects, creating them in consistent formulations can be a challenge, making synthesized versions of the compound a common alternative for therapeutic research. However, they noted that with careful cultivation and processing, it is possible to make extracts in consistent formulations. “A major challenge with natural extracts lies in achieving a consistently stable compound profile, especially with plants; however, mushrooms present a unique case,” the researchers wrote. “Mushroom compounds are highly influenced by their growing environment, encompassing factors such as substrate composition, CO2/O2 ratio, light exposure, temperature, and microbial surroundings. Despite these influences, controlled cultivation allows for the taming of mushrooms, enabling the production of a replicable extract.” The researchers recommended more research, noting that there could be clinical advantages to using a natural mushroom extract instead of synthesized psilocybin. “Our findings need to be confirmed in human studies but they do suggest that there may be therapeutic advantages to psilocybin-containing mushroom extract over chemically synthesized psilocybin, when both are administered at the same psilocybin dose,” said Lerer.

https://hightimes.com/

New York Governor Begins Review of Weed Legalization Rollout

New York Governor Kathy Hochul announced on Monday that her administration will conduct an assessment of the state’s rollout of legal recreational marijuana, saying that the review is needed to ensure the success of the regulated cannabis market.  New York lawmakers passed legislation legalizing recreational pot nearly three years ago, but the rollout of regulated sales has been plagued by lawsuits and other delays. More than a year after the first licensed recreational pot shop opened in December 2022, only 70 retailers selling adult-use cannabis have been licensed statewide. The figure includes Conditional Adult-Use Retail Dispensary (CAURD) storefronts and CAURD delivery-only services, licenses that were reserved for applicants with past cannabis convictions, as well as previously existing medical marijuana dispensaries that have been co-licensed to sell recreational weed. In the meantime, the shortage of licensed retailers coupled with the end of criminal penalties for cannabis possession has led to an explosion of unlicensed pot shops, particularly in New York City. An estimated 36,000 unlicensed retailers have opened statewide, according to a recent report, including approximately 1,500 in the Big Apple alone. Critics of New York’s regulated cannabis rollout say the situation threatens the viability of the legal industry. Earlier this year, the Democratic governor characterized the rollout of legal cannabis as a “disaster,” saying that it was unlikely that the program could be improved without significant changes to the Marihuana Regulation and Taxation Act (MRTA), the 2021 law that legalized recreational marijuana in New York. Hochul made the comments as she responded to questions about the rollout from the editorial board of the Buffalo News, noting that some areas of New York City have multiple unlicensed weed shops on the same block. “It’s not every street corner,” Hochul said in January. “It is every other storefront. It is insane.” On Monday, Hochul said that her administration would complete an assessment of the rollout to identify opportunities to improve the program and ensure its success. The review will be led by Commissioner for the Office of General Services Jeanette Moy, who along with a team of state government leaders will embed with the New York Office of Cannabis Management (OCM) for at least 30 days. “Today, we take the first step in revamping New York’s legal cannabis industry to ensure its long-term success,” Hochul said in a statement on Monday. “I have full confidence in Commissioner Moy’s ability to identify areas that need improvement, establish standards and processes across agencies, and jumpstart the next phase of New York’s legal cannabis market.” Lauren Rudick, an attorney who has helped clients submit more than 100 applications for cannabis business licenses, said she appreciates Hochul’s announced review. She added that she hopes the assessment will foster a more transparent process for submitting applications and addressing problems that might come up as applications are reviewed. “We want to have a system that is repeatable and predictable, so that when someone comes to us for licensing, we can give them a sense as to what they can expect,” Rudick told the New York Times. “But as of right now, it’s ‘be flexible and pivot or die,’ because we just never know what the state is going to throw at us.” The assessment of New York’s cannabis rollout will include a complete review of the organizational structure, systems and process at the OCM. The review will focus on improving the time it takes to process an application and reducing the application-to-opening timeframe for new cannabis businesses. Moy’s team has also been tasked with developing key performance metrics and an executive-level licensing dashboard to give policymakers a comprehensive view of the state’s licensing activity. The review will also include efforts to identify and implement policy changes that will streamline the application and licensing process and the development of three-month and six-month plans to continue improving the performance of cannabis regulators. Hochul’s review of New York’s rollout of regulated recreational weed is also being welcomed by business operators who have already gone through the licensing process. New Yorker Christopher Louie moved to Colorado to start the brand Made in Xiaolin in 2018. He recently returned to the Empire State to launch the brand there, but says the “rollout of regulated cannabis in New York was a bit fumbled.” “It is clear that regulators tried to be quick with the rollout, and it has posed some interesting challenges,” Louie wrote in an email to High Times. “For example, the wholesale market is not favorable for our brand right now, and we’re being forced to lower margins on both sides. Additionally, the way the illicit market and the legal market are currently coexisting is eerily reminiscent of the California market – which is not something anyone wants to duplicate. We are hopeful for the future, though, and continue to see small strides toward a more successful legal market that we are proud to be a part of.” Sasha Nutgent, director of retail at Housing Works Cannabis Co, the first licensed recreational cannabis dispensary to open in the state, said that the review is “absolutely necessary.” “The rollout of licenses has been extremely slow and is negatively impacting the livelihoods of hundreds of applicants across the State,” Nutgent wrote in an email. “There have been numerous missed opportunities in the legal adult-use cannabis industry, and hopefully Hochul’s move will help to rectify them.”

https://hightimes.com/

Will Abbott Elementary Ignite Honest Weed Depictions on Network TV?

February 22, 2024, marked a relatively low-key historic moment in television history, with ABC’s Abbott Elementary airing one of the most authentic depictions of real-life cannabis consumers on a major network television channel in nearly 30 years. In season 3, episode 4 (“Smoking”), several teachers and faculty discuss their various vices, ranging from vaping and drinking wine to microdosing and different kinds of cannabis consumption. In the episode, Quinta Brunson’s character, Janine, candidly discusses her medical marijuana use while questioning Jacob’s vaping. Despite the on-screen portrayal, Brunson, who also portrayed a pot character in A Black Lady Sketch Show segment, said she isn’t much of a smoker. Also, in the episode, Mr. Eddie mentions his preference for a weekend protein edible bar, prompting Principal Ava Coleman to comment on him making drugs boring. Other staff reveal their CBD use for joint pain or relaxing with a blunt in the bath. At the same time, characters like Mrs. Howard represent lingering cannabis stigmas.  The authentic-sounding exchange in a school setting immediately stands out as one of the most honest depictions of weed use a network channel has ever shown. Is this a sign that the major channels might be catching up to streaming and basic cable networks?  The major network channels (ABC, Fox, NBC, and CBS) have historically been hesitant to depict cannabis in a positive or normalized manner. In a 2020 deep dive into the history of cannabis on TV, writer Jacob Trussell noted that the 1967 revival of the cop drama Dragnet was one of the first productions to feature cannabis since propaganda films of the 1930s and a relatively harmless storyline on The Andy Griffith Show. In the Dragnet episode, Trussell noted that while marijuana is depicted as a drug similar to heroin, those accused of using it did push back on the assertion that it was a gateway drug.  A decade later, shows like Sanford and Son and Barney Miller helped depict cannabis in a more realistic light, with users becoming forgetful and nicer after consuming. The early ’80s continued this trend until the passage of the Comprehensive Crime Control Act of 1984 and the ushering in of the propaganda and the Just Say No campaign.  The trend continued into the 90s, when viewers saw a proliferation of anti-drug episodes and TV specials, with arguably the best example being the 1990 animated film Cartoon All-Stars to the Rescue, which saw virtually every childhood cartoon star of the time joining up to battle marijuana use. The film, financed by McDonald’s, was simulcast across all the major networks and many independent stations on April 21, 1990.  In 1997, Congress took a step further, appropriating over $1 billion to advertise anti-drug messages. The action led to anti-drug messages on shows ranging from dramas like ER to comedies, including The Drew Carey Show. 1997 also saw Murphy Brown’s honest look into cannabis and cancer treatment, marking the most significant breakthrough in plant normalization at that time. The government-backed propaganda program quietly ended in 2000, as did any major plant discussions for the next several decades on network TV.  Since the early 2000s, we’ve seen a slow and steady increase of either positive or neutral depictions of cannabis use, first on basic cable channels and now on streaming services and other online platforms like YouTube. But still, major network television has lagged.  Trussell observed that while TV demonizes cannabis less now, it still often resorts to outdated stereotypes. “But at the same time, especially since 2020, I feel like I’ve seen less TV shows go out of their way to make cannabis the crux of the plot of an episode — and I think that’s a positive thing,” he said. “Cannabis is just not a controversial storyline anymore because the plant has become more normalized.” Trussell noted that while The Simpsons touched on medical cannabis nearly 20 years ago, the episode was regressive in its depiction. Similarly, 1993’s episode of Roseanne, titled “Stash from the Past” ultimately normalizes pot use, but only after parents Roseanne and Dan come down on the kids hard for having some flower–only to realize it was an old stash of theirs.  Other TV experts noted that NBC’s Community made a few passing jokes about cannabis use, including season five episode nine’s “VCR Maintenance and Educational Publishing,” where Britta says, “I know we’re in E9 in the east wing. I know because it smells like weed. Not my weed.” In a decade-old Reddit thread, Community writer Tim Saccardo commented on the post explaining that NBC’s standards and practices made the show insert the word ‘not’ into Britta’s line. Around the same time, shows like Bob’s Burgers introduced a weed farm into their world in 2012, while Modern Family mentioned an over-the-top pot shop owner for a one-off spot in 2015.  In all, the pickings have been slim on the Big 4 channels.  Unlike Murphy Brown, which received blowback from the DEA, Abbott has mainly received positive feedback for its depiction of cannabis consumption. Many noted the importance of normalizing cannabis use. “I think what’s notable about Abbott Elementary is that Janine and Gregory’s drug use isn’t really the sole butt of the joke,” Kayla Cobb, senior TV reporter for The Wrap.  Steve Bloom, publisher of the website CelebStoner, enjoyed the segment but felt some of the dialogue around infused protein bars “didn’t make any sense in the conversation.” Despite some minor issues, Bloom and other writers felt the Abbott episode did a good job of normalizing cannabis use among women and people of color. Comedian and TV writer Ashley Ray offered similar takes, praising Abbott for making its characters consumers without being pot stereotypes. “It is very rare that you see a show embracing a major character smoking pot, and it’s not their entirety.” Ray added, “It also was great because you rarely see women of color, black women, smoking pot in shows.”  Both Ray and Bloom also acknowledged Netflix’s Survival of the Thickest, starring Michelle Buteau, for its normalization of black and minority characters consuming cannabis in their everyday lives. Ray interviewed Buteau for her podcast TV, I Say, where they discussed the everyday pot use on the show. “They will just be sitting around an apartment together, hanging out as friends, and they smoke,” Ray explained.  Despite Abbott‘s positive impact, most experts feel that network TV will continue to slowly change its depiction of cannabis. The hesitance comes from various sources, including ongoing federal laws and the impact of conservative viewer blowback, which may affect what matters most to the networks: a show’s revenue potential.   Despite the uncertain future, most were optimistic after the latest development. “We can now show a teacher on TV speaking openly about using cannabis for mental health reasons and not have the episode revolve around how ‘morally bankrupt’ she is like we may have seen in the eras of ‘Just Say No!”’ and DARE,” said Trussell. Others, like Bloom and Cobb, speculate that both Abbott and Murphy Brown showcase that a network show may not be able to discuss the plant until it has established itself as an award-winning, lucrative show.  While major networks slowly ease into the new normal of weed use, streaming and cable are blowing past it. On paid cable, Broad City, a once groundbreaking women-, weed-centric comedy, ended five years ago. Meanwhile, Netflix has surged ahead from its past-era stoner stereotypes on the now-canceled Disjointed. It’s now producing more real-life depictions of everyday pot smokers, including women of all adult ages, as evidenced by shows like Survival of the Thickest and Grace and Franky.  While Abbott Elementary should be celebrated for breaking through a nearly 30-year wall on network TV, we should also take a moment to wonder why it has taken so long. With network TV facing more competition than ever, wouldn’t it be wise to create shows that relate to their viewers? You’d think so, but here we are. 

https://hightimes.com/

Lil Wayne Had To Operate Drug-Free Workplace for $9M in Pandemic Business Aid

Lil Wayne’s private life is one thing, and his business drug policy is another, recently unveiled documents indicate. In 2021, Lil Wayne received $8.9 million for his Young Money Touring Inc. company, like many other businesses impacted by pandemic shutdowns, and he was forced to abide by drug-free workplace standards in order to secure the loan. Business Insider reports that recently uncovered documents reveal Lil Wayne had to establish a drug-free workplace or lose out on millions in Small Business Administration (SBA) loans that rolled out after the COVID pandemic. The SBA began approving loans greater than $500,000 on Oct. 8, 2021. The since-closed Shuttered Venue Operators Grant (SVOG) program, which was designed to help struggling music venues that depended on in-person events avoid bankruptcy during the pandemic. In 2021, Lil Wayne was forced to disclose to the government that his touring company was a “drug-free workplace.” The “dangers” of drugs—including his favorite, cannabis—were communicated to his employees, and they were told they could be punished or be forced to go to rehab in the event that they smoke weed or do other illegal drugs. These workplace drug policies have been in place for some time: On Nov. 18, 1988, Congress enacted the Ronald Reagan-era Drug-Free Workplace Act which installed mandatory drug policies for employers across America. Business Insider posted the actual document naming Dwayne Carter Jr., his real name, and the drug-free workplace requirements that he was forced to communicate to his employees. The report indicates that over $200 million in SVOG grants were given out to companies run by A-list artists. The Paycheck Protection Program (PPP)—which is not related to SVOG loans, but can benefit similar businesses—was designed to help businesses keep their employees on payroll. A report of SBA data released in January found that 92% of PPP loans were granted full or partial forgiveness. A lot of this focus on personal life is unfairly directed at celebrities, some said, when they were asked for comment. “When you have social status, your substance use is treated in a different way,” Harold Pollack, a public-health expert at the University of Chicago, said. “They don’t brutalize a lot of celebrities for behaviors that we would very harshly treat in people with less prestige.” Lil Wayne is invested in the cannabis industry, and talks about it often. In 2019, Lil Wayne announced his cannabis brand GKUA Ultra Premium. “I used to just want to get high, now I smoke to get inspired,” Lil Wayne said in the announcement. “With GKUA, I’m sharing a feeling that I love.” “We are working closely with a half dozen of the most experienced growers in Northern California in the Emerald Triangle,” GKUA’s executive team told High Times at the time. The initial first three strains were GKUA VIP, Hollygrove, and Uproar.  “Shoutout to my weed man, shoutout to my lean man,” Lil Wayne raps in “Trippy feat. Juicy J” on I Am Not a Human 2. He continues with “The ground movin’, I’m seeing shit, I’m blowing like I’m stuck in traffic. I’m smoking on that strong, got me coughing like I’m getting buried.” He also drops some bars in “Codeine Dreaming” from Kodak Black’s Project Baby 2: All Grown Up released in 2017. The Business Insider report also identifies Post Malone in the report, who was forced to do the same for his tour company and received about the same amount of money. Rolling Stone reported in August 2023 that other artists like Chris Brown, Steve Aoki, Nickelback and others also received SVOG loans for their businesses, most of which depended on in-person events. When applying for the pandemic relief aid for his Posty Touring Inc. Post Malone also said that had to warn his employees against using drugs and was granted $10 million in government aid. While Post Malone is a fan of psilocybin mushrooms, saying “Yeah, I take shrooms. I like shrooms—not as much as I used to.” That said, cigarettes and Bud Lights are his main vices by most accounts, though he’s currently working on “slowing down” on alcohol in his recent push to get in better health. In 2019—the same year that Lil Wayne launched GKUA Premium cannabis brand—Post Malone launched Shaboinks with Sherbinski’s, a hemp pre-roll company, which is legal at the federal level. The media reports do not show where the SVOG funding went to, whether it be employees of those businesses or other expenses. As pandemic relief programs become a thing of the past, media reports that look into how government loans were used have been revealed. 

https://hightimes.com/

Ohio Cannabis School Receives Accreditation

The Cleveland School of Cannabis (CSC), located in Independence, Ohio, announced on March 6 that it is the first cannabis school in the U.S. to be recognized through the Middle States Association-CESS. “The accreditation of CSC by Middle States Association-CESS (MSA-CESS) marks a significant step forward for the cannabis industry, driven by a broader acceptance of cannabis and its related fields within the formal education system,” CSC wrote in a press release. “With over 1,100 graduates, CSC has already made substantial contributions to the workforce and knowledge base of the cannabis industry. This formal recognition could pave the way for further advancements in cannabis research, education, and professional development, bridging the gap between the burgeoning cannabis market and academic legitimacy.” Technically, the college received accreditation in December 2023, but the school only recently published the announcement. For more than 130 years, Middle States Association-CESS has been operating as a voluntary non-profit association that evaluates and performs accreditation of both public and private schools. Accreditation demonstrates if a school is maintaining a specific level of quality and performance through five categories: foundations, governance and organization, student well-being, resources, and teaching and learning. The press release explained that this decision was made in part because the federal government is researching and discussing cannabis rescheduling. “Following a recommendation by the U.S. Department of Health to reschedule cannabis as a Schedule III substance, CSC’s recognition by the Department of Education could be an early indicator of changing attitudes within the federal government towards cannabis,” CSC wrote. “Rescheduling cannabis would acknowledge its medical benefits and could notably impact the regulatory landscape. This could potentially ease restrictions on research, banking, and taxation within the cannabis industry.” CSC’s accreditation was awarded in part because it recently moved into a new building with access to a grow lab, processing lab, kitchen, mock dispensary, and virtual reality lab. “CSC’s newest additions were developed to upgrade the learning experience for students to enhance student learning through practical, hands-on education in cannabis cultivation, processing, cooking, and sales,” the press release stated. “This approach not only readies students for the cannabis industry’s intricacies but also boosts their job prospects by offering a deep dive into the sector.” Additionally, CSC utilizes more recent technological innovations such as VR and gaming engines to create digital versions of their labs for remote students to utilize. For example, it hosts a 16-week “My First Plant” virtual course to teach consumers how to grow cannabis at home. A spokesperson from the U.S. Department of Education told The Canton Repository in a statement that while CSC is accredited, the school “is not approved by the Department to participate in Title IV or other programs under the Higher Education Act.” Students attending accredited schools are eligible for financial aid, but in this case it’s not clear that CSC would qualify. CSC has been operating since 2017 and has had 1,100 students graduate through its various programs. On Feb. 29, Cannabis Business Times published an interview with CSC founder Austin Briggs. “It hasn’t been easy running a cannabis business in Ohio,” Briggs said. “For things as little as occupancy permits, we had to fight tooth and nail. For a largely conservative state, Ohio citizens have shown wide support for cannabis, both medical and recreational. But there still seems to be a tremendous amount of resistance from the government in supporting cannabis programs in Ohio. With the passing of Issue 2 and our accreditation, I’m hoping this will be a turning point for Ohio policy.” CSC President Tyrone Russell also provided a statement regarding how the school trains students and connects them with jobs in the industry. “Workforce development and education is the key to socioeconomic mobility,” said Russell. “Companies have to hire people from their communities, and that only happens if those community members have access to education. In Ohio, you can go to your Ohio means jobs office, and get a grant to be a barber, welder, truck driver, contractor, or nail technician, but not to work in cannabis.” Other educational institutions have been increasing cannabis education over the past few years. Back in 2019, the University of Maryland announced one of the first medical cannabis Master’s degree programs. Since then, many other institutions have introduced some form of education program or degree revolving around cannabis. Last November, the University of Mississippi School of Pharmacy announced a new medical degree in medical cannabis and dietary supplements. Earlier this year in January, Roanoke College in Virginia announced its launch of a new cannabis studies program. I commend the faculty for developing a transdisciplinary academic program that fills a significant educational gap,” said vice president for academic affairs and dean of Roanoke College, Kathy Wolfe. “With this program, Roanoke College continues to lead in science, policy, business and community engagement.”  Professor DorothyBelle “DB” Poli helped to establish the new program. “Students are interested in this industry,” Poli said. “Being the first in the state to approach cannabis from a scholarly perspective is inventive and entrepreneurial. We hope to help bring clarity to tough problems by creating a truly multidisciplinary think tank.”

https://hightimes.com/

Weed Megacorp To Exit Maine Adult-Use Market

Curaleaf, one of the world’s largest cannabis companies, is exiting the adult-use cannabis retail market in Maine with the sale of its licensed dispensary in South Portland. The company’s sole recreational marijuana shop is being sold to Foliage Cannabis Co., which has already begun operations at the retail location, according to a report in local media. Online news source Mainebiz reports that Curaleaf and Foliage Cannabis have agreed to the transfer of ownership of the South Portland dispensary, although the terms of the deal have not been released. The retail site will be the second dispensary in Maine for Foliage Cannabis, which operates its original shop in South Portland less than a mile from the new location. Curaleaf continues to operate medical marijuana dispensaries in Bangor, Auburn, Wells and Elsworth, Maine, according to a listing for the state on the company’s website. A company spokesperson for Curaleaf confirmed the move, writing in an emailed statement that “We exited adult use, but remain in the medical market with four stores and have no plans to exit medical.” Curaleaf mentioned the transaction on March 6 when it reported results for the fourth quarter of last year. The announcement had few details, saying only that the company had “entered into an agreement to sell our Maine, adult-use store.” In a press release, the company reported it had generated $345 million in revenue in the fourth quarter of 2023, representing an increase of 4% quarter-over-quarter. Curaleaf’s fourth-quarter financial also reporting shows that the company’s revenue for the year totaled $1.35 billion, up 6% from 2022. Profitability was elusive, however, with the firm showing a 2023 net loss of $281.1 million, the equivalent of 39 cents per share. Curaleaf owns and operates 145 retail cannabis locations in 17 states. Worldwide, the company employs about 5,600 people. Alexis Soucy, a spokesperson for the Maine Office of Cannabis policy, said that Curaleaf will complete the sale of the retail location once the business has been approved for an active license. The conditional license the shop is operating under is scheduled to expire in October. Until the active license is approved, the two companies have arranged for Foliage Cannabis to use its name and branding at the dispensary to be transferred.  Three years ago, Scott Reed, Curaleaf’s general manager in Maine at the time, said that the company had big plans for the state as it entered the recreational market in April 2021. “We have been proudly serving the Maine medical market with top-quality, locally grown flower, and exceptional customer service for nearly a decade, and we look forward to expanding those offerings to our adult-use customers,” Reed said at the time, according to the report from Mainebiz. Reed left Curaleaf in July 2022 when the company went through a round of downsizing. He is now the co-owner of Foliage Cannabis Co. with his partner Scott Lever. Together, they’ve been able to independently raise the money needed to open the two retail locations, giving the partners far more flexibility than many other cannabis companies. “We’re self-funded, so we’re different from a large company with lots of investors,” Reed said. “We can be nimble.” Earlier this month, the Office of Cannabis Policy released data showing that the state’s retailers rang up $18.01 million in recreational marijuana sales last month, a figure that was up 28.3% from the $14.05 million in sales in February 2022. Despite the success of Maine’s adult-use cannabis industry as a whole, the picture isn’t as rosy for some companies in the market. A total of 20 licensed businesses including 11 cultivation sites, four manufacturing facilities and five retail dispensaries exited Maine’s recreational marijuana market in 2023. Overall, however, the industry is still growing. Despite the shuttered companies, the number of cultivation sites in Maine remained stable from 2022 to 2023, while the number of retailers increased by 27 and the number of manufacturers rose by 13. Curaleaf’s exit from Maine is not the first time the company has left a state’s recreational cannabis market. In January 2023, Curaleaf announced that it was leaving the mature markets of California, Oregon and Colorado. That announcement was followed by the company’s exit from adult-use cannabis markets in Michigan and Vermont. Curaleaf executive chairman Boris Jordan said during a third-quarter investor conference call in November that the company is exiting “low-margin, low-growth” markets it now serves in a bid to improve profitability.  “Throughout 2023, the company’s been focused on improving efficiency metrics and dialing in operations to maximize its existing base,” Jordan said, according to a report from Cannabis Business Times. “We have taken significant steps to eliminate redundancies, strategically reduce headcounts [and] exit unprofitable markets. Most of these actions occurred in the first half of the year. And in the third quarter we took the final steps in our asset optimization plan.”

https://hightimes.com/

Study: No Association Between Rec MJ Laws, Use Among Middle School Youth

A long standing argument against the legalization of cannabis has cited that legal access could lead to an increase in youth cannabis use. As states across the country continue pushing forward with reform measures, research is continually providing insight on just how merited that assertion is in actuality. Fresh off the heels of a recent study showing the prevalence of delta-8 THC use among high school seniors — a hemp-derived cannabinoid that is widely available outside of the legal cannabis industry and in states with or without legal cannabis programs — some may wonder how many teens are using cannabis in recreational states and whether reform has escalated these trends. A new study published in the journal Addictive Behaviors looked to investigate how legal cannabis laws have impacted adolescent use and examined lifetime and past 30-day (P30D) cannabis use among middle school-aged adolescents in Nevada versus New Mexico. It ultimately affirmed what many studies in the past have: Initiating state-licensed cannabis sales is not associated with an increase in cannabis use among young people. We’re still exploring the impacts of cannabis use, for better or worse, given the limited scope of research on the plant over the last several decades. However, despite the many benefits cannabis and its compounds may offer us, it’s widely accepted that cannabis use during adolescence can be especially impactful on development.  To examine how adult-use cannabis legalization has influenced adolescent cannabis use, researchers behind the recent study used data from the 2017 and 2019 NV Youth Risk Behavior Survey and the NM Youth Risk and Resiliency Survey, state-run surveys for Nevada and New Mexico respectively designed to monitor health behaviors among U.S. students. Researchers used difference-in-difference analyses to compare behaviors surrounding lifetime and past 30-day use in Nevada and New Mexico during the same period. At the time, Nevada had legal adult-use cannabis sales and New Mexico did not. According to the analysis, the odds of lifetime and past 30-day use increased in both states during the observed time period, specifically among students who were female, older, non-white or attending a Title 1 school.  Ultimately, researchers noted that there was “no difference in lifetime and P30D marijuana use by adult-use sales status.”  Rather, cannabis use in both states followed similar trajectories. Researchers still noted this as a point of concern, given the negative health consequences of cannabis use at an early age, though whether or not cannabis was legal in a given state didn’t appear to be an influencing factor. “We did not find compelling evidence that implementation of adult-use marijuana sales was associated with an immediate increase in lifetime or P30D marijuana use among middle school youth in Nevada which aligns with previous research,” the study notes. Indeed, many other studies from the past have come to a similar conclusion: Cannabis reform does not appear to be correlated with an increase in use among young people. A 2022 policy paper looked broader, reviewing data on consumption among eighth, 10th and 12th grade students, finding that youth consumption either “decreases or remains flat in regulated markets.” “State legalization of cannabis has not, on average, impacted the prevalence of cannabis use among adolescents. In other words, states with medical and/or adult use laws are not seeing larger increases in adolescent use relative to states where use remains illegal,” the report states, additionally noting that educational early prevention methods can help to combat youth consumption. The same appears to be true when focusing explicitly on medical cannabis laws, as a 2021 study “found no evidence between 1991 and 2015 of increases in adolescents reporting past 30-day marijuana use or heavy marijuana use associated with state MML (medical marijuana law) enactment or operational MML dispensaries.” Another study tackled an adjacent inquiry: Does a state’s legal or illegal adult-use cannabis status impact children’s attitudes around cannabis use and perceptions of its risks? Researchers concluded that individual, child-level characteristics were the primary factor influencing young people’s attitudes toward cannabis, not state policy. A recent report from the US Centers for Disease Control and Prevention further compounds these findings, showing a steady decline in cannabis use in high school students from 2011 to 2021. The market is still in its infancy, and we’re bound to see more reports on the topic as time goes on. But as it stands, the argument that legal cannabis will increase use among young people appears to have weak footing, and naysayers may need to look elsewhere for concrete arguments against reform.

https://hightimes.com/

Cannabeginners: Cannabichromene (CBC) Explained

Despite being made through the same biochemistry that converts CBG into THC or CBD, Cannabichromene (CBC) has received a lot less research and attention. Like CBD, CBC is non-intoxicating so it won’t make you feel high, and it has some unique and promising medical benefits with more research happening every year. While CBC has been less researched than some of the more well-known cannabinoids, there are still hundreds of patents on it.  There is some debate over which group of researchers were the first to isolate CBC in 1966, but it was either Raphael Mechoulam and his colleagues looking at hashish or another team using a different extraction method and hemp. Since CBC was first isolated from cannabis, as is the case with many other cannabinoids, CBC or CBC-like compounds have been found in non-cannabis sources. CBC has been found to be “the second most abundant phytocannabinoids in some strains of marijuana in the United States,” and is specifically “more plentiful in freshly harvested dry-type cannabis material.” CBC is made through a similar chemical conversion that creates THC or CBD, beginning with olivetolic acid and geranyl diphosphate combining to make CBGa. In the next step, the CBGa combines with a CBC-synthase to form CBCa, which is decarboxylated into CBC. Research has also shown that, similar to the genetic mutation that allows for CBG-rich cultivars, there is a mutation to allow for CBC-rich cannabis plants as well. Just like THC can be further decarboxylated into CBN, CBC can be decarboxylated to a very poorly researched cannabinoid, Cannabicyclol (CBL).  Word nerds out there might be thinking, “I know what the “cannabi” half of cannabichromene means, but what is a chromene?” Chromenes are chemicals commonly found in nature which are used in a wide range of products including food, cosmetics, and agrochemicals. Just like cannabis has cannabichromene, all kinds of other plants have their own specialized chromenes. Chromenes are such an incredibly broad class of chemicals that, included in its scope, are groups of chemicals like alkaloids and anthocyanins.  CBC has been demonstrated to be an effective painkiller in multiple studies, both as an analgesic and antinociceptive pain reliever. Though most of the research on CBC as a painkiller has focused on animals, it is believed to have similar effects in humans. The research around CBC and pain has also shown it to be an effective tool for reducing inflammation, with one study calling it the cannabinoid 2nd most likely to produce anti-inflammatory effects. What really makes the anti-inflammatory effects of CBC unique is that they are completely independent of the endocannabinoid system and other commonly used methods of action, which still has researchers puzzled. In a clear example of the ensemble/entourage effect, the dose-dependent anti-inflammatory effects of CBC were “augmented when CBC and THC were co-administered.” Studies have shown that CBC can be an effective treatment for fungal activity and has antibacterial effects, noting the “antibacterial activity was strong, and the antifungal activity was mild to moderate.” So while CBC may not be a way to deal with the Last of Us cordyceps zombies, it may be able to do something for your athlete’s foot. Another very unique property of CBC is that it works as a neurogenic, it helps with creating new brain cells, aiding in healthy recovery after brain damage by controlling neural stem/progenitor cells. While most cannabinoids work to reduce pain and inflammation, CBC, CBG and CBD appear to be the only cannabinoids presently known to possess benefits for aiding in spinal cord or brain injuries.  CBC’s ability to help the brain isn’t just limited to physical ailments, it also has been shown to display “pronounced antidepressant effect[s].” Another study, which looked at both THC and CBC, found that CBC “may contribute to the overall mood-elevating properties of cannabis,” but the researchers noted that the “exact mechanism underlying such activity is still unclear.” While these findings are very promising, these studies were done on rodents, not people, and people are not the same as rodents, so more research needs to be done looking at CBC in humans.  The main reason why researchers have had trouble pinning down the exact mechanism through which CBC interacts with our body is that it isn’t just one method of action. CBC has been shown to have “ low affinity for CB1 and CB2 receptors,” meaning it doesn’t have a strong interaction with our endocannabinoid receptors. Instead, CBC has activity with various TRP receptors (sensing pain) and adenosine receptors (where caffeine interacts). CBC is the lesser known relative of THC and CBD, made through the same chemical conversion process from CBGa. Despite being the subject of a lot less research than other cannabinoids, CBC has been proven to have a range of unique medical properties including acting as an antifungal, antibacterial, anti-inflammatory, anti-depressant, painkiller, and neurogenic compound.

https://hightimes.com/

Estate Grown

About two and a half hours north of San Francisco lies a lesser-known wine region within a small valley that—with walk-in availability, bottles of pinot noir priced around $40, farm-fresh cheeses, fine dining, apple orchards, vineyards, and redwood groves—feels unpretentious, but appropriately vacation fancy. Driving there on the first weekend of November 2023, the grapevine leaves are turning rasta colors—red, green, and gold—as the valley unfolds, driving west towards the Pacific Ocean. The rolling hills and roadsides are primarily lined with evergreen oaks and redwoods, cut with the occasional yellow-leaved alder or statuesque giant golden ginkgos. After Boonville, in a tiny town called Philo, there is a unique cannabis hospitality concept, a hotel that also grows its own cannabis and offers it for purchase onsite. Checking into The Madrones, the lobby is on the left, within the giftshop that leads to the restaurant. On the right, there’s a 1920s Art Deco apothecary-themed cannabis retailer, The Bohemian Chemist. While stepping outside to puff a joint at most hotels feels like an anxiety-ridden exercise in not getting caught, The Madrones boasts an open-air cannabis consumption lounge in an enclosed courtyard behind the lobby. The model feels like a winery tasting room where you’d enjoy a taste or a glass of wine in an opulent environment onsite and then buy a bottle to take home. The 2023 cannabis harvest is complete, and The Bohemian Chemist is hosting its first cannabis pick-up party for its club members. The hotel is in the Anderson Valley in Mendocino County, the southernmost point of the famed Northern California cannabis cultivation region, the Emerald Triangle. The idea is that club members pick up a box of freshly harvested, dried, and cured cannabis flowers, then join in on a discounted weekend at the hotel and a few other harvest-themed activities. While harvest-themed parties are common in the wine industry, applying the concept to release this year’s cannabis crop is quite novel. The Bohemian Chemist’s harvest weekend starts with a Friday evening cannabis and wine pairing led by Jamie Evans, the founder of the cannabis blog and lifestyle brand The Herb Somm. “I think what makes the Anderson Valley so unique is the growing region that we have here,” Evans says. “And so just some fun facts about Anderson Valley: it’s approximately one mile wide and 15 miles long, and it’s surrounded by redwoods. And down the middle of the valley, you have the Navarro River, and we’re actually quite close to the coast as well. So, factoring all those things in, it’s an ideal region for growing grapes. We’re getting pinot noir, chardonnay, and cool-climate grapes that do extremely well here.” To pair the wine and cannabis, Evans focuses on terpenes. “If you haven’t heard of terpenes before, they are the organic compounds that give cannabis all the wonderful aromas and flavors that you receive when you’re smelling through your favorite strains, but they’re not just found in cannabis alone,” Evans explains. “They’re found in many fruits, flowers, and spices; they’re even found in wine.” The first pairing combines The Bohemian Chemist’s African Sherbet—Lemon Sherbet and African Orange bred by Equilibrium Genetics—with a 2022 pinot noir rosé from Long Meadow Ranch winery. The cannabis and the grapes were grown within a mile of each other.  The African Sherbet has a light floral aroma. Evans passes out wine glasses of pink rose petals to smell alongside sniffing wine glasses of African Sherbet and the rosé, which tastes like white peaches. “This year, we’ve really been learning a lot. As far as our cannabis, we’re leaning a lot into landrace, a lot into old-school varieties,” says Jim Roberts, who owns and runs the cannabis venture and hotel with his partner in business and life, Brian Adkinson. The second pairing is a 2019 Anderson Valley chardonnay with an African landrace, Swazi Gold. Both express an apple/pear aroma and taste citrusy. “What I like to say is light, uplifting strains with light, crisp white wines,” Evans says. “More bold sedating strains. I like to pair that with red wine to really keep it balanced, more relaxing.” When I meet Adkinson, he tells me he and Roberts met in San Francisco’s Castro District in 2012. He’s originally from Kansas, and Roberts is originally from Southern California. Roberts used to have an interior design business, which is the current location of The Madrones. “The Anderson Valley is unique in that it’s an east/west facing valley instead of a north/south facing valley in California. It’s an east/west valley that actually buts up against the coast, and that’s what creates our ideal climate conditions; we literally pull the fog in at night—it gets really, really cold—and then push it out during the day,” Adkinson says as we begin the tour of their homestead cannabis grow. “This particular spot is the highest spot in the Anderson Valley looking down the length of the valley.” The property has rose and shade gardens, with a 5,000-square-foot cannabis grow in front of the home where Adkinson and Roberts live. These days, Adkinson focuses on running the hotel, while Roberts focuses on cannabis cultivation.   Roberts’s mother, Rosemary Roberts, introduced him to weed in high school as she grew it and gave it to him. “I’m jumping right out there; I’m completely out of the closet for a second time,” Roberts says of his decision to start a cannabis brand in 2020 after previously cultivating under Proposition 215. “Everything’s been a fight.” Not only have they had farming challenges and issues with banking for the aspect of their business that does not include cannabis cultivation due to mere association, but they’ve also had to combat the stigmas around cannabis use. One of their strategies to do that relies on high-end design. “We knew when we created our packaging we had to have something that was going to be palpable and approachable to a bougie wine person,” Adkinson says. “We decided that instead of doing that ’60s/’70s vibe, that we wanted to push things back to the 1920s, [and] we went with a real Art Deco vibe.” The packaging—which won a 2023 Clio Award for packaging brand design—has elements of Egyptian-inspired imagery, like a scarab, that was popular in the ’20s. The retail shop displays jars Roberts purchased through an auction house, featuring items from a Hungarian pharmacy that had been in the same family since 1810. Tom Butler and his wife Cristal Butler—who live in Roseville, California, near Sacramento—became members of the cannabis club at The Bohemian Chemist about three weeks before the harvest event while they were previously visiting Anderson Valley. They returned to pick up their shipment—a box including flowers alongside pre-rolls and vape cartridges—to participate in the weekend’s events. “I’m [retired], and she’s retiring in two months,” Tom Butler tells me after we finish the farm’s drying room tour. “We’re going to start traveling more. We like to come up here and spend time in Mendocino.” Tom Butler says his favorite type of cannabis he’s tried from The Bohemian Chemist has been Blue Dream and that he’s more of an evening partaker for relaxation and typically uses a Pax flower vaporizer. The Butlers are staying at The Madrones’s adjacent property, The Brambles, located in a redwood grove. While there’s no smoking inside the hotel rooms, visitors staying at The Madrones or The Brambles have plenty of space to smoke outside. I take advantage of this fact, puffing on Maui Pineapple pre-rolls—The Bohemian Chemist calls them “Giggle Sticks”—before and during the harvest festival dinner. There’s nothing quite like a trip to witness the beauty of Mendocino County firsthand, especially in the fall. My weekend getaway to the Anderson Valley was filled with delicious food, wine, and sungrown cannabis. “This is the off-the-beaten-path experience,” Roberts says. “It’s an authentic working community.” This article was originally published in the March 2024 issue of High Times Magazine.

https://hightimes.com/

Growing Ganja in Jamaica

Ganja in Jamaica is more than just the cannabis plant; it’s a culture, a way of life, and an expression of people from varying cultural backgrounds who ended up on the Caribbean Island via the plantation model. The British monarchy was responsible for the cultural clash that saw enslaved Africans and indentured laborers co-mingling and participating in the smoking of ganja after a day’s work in the sugarcane plantations. This unique phenomenon gave birth to Rastafari, a religious and political movement rooted in African culture with Emperor Haile Selassie I from Ethiopia as its redeemer, the red, green, and gold colors, and the use of the chillum pipe. Furthermore, the profound impact of Indian influence on the vegan diet, the growing of dreadlocks, and the use of ganja as a sacramental herb have contributed to ganja being an endemic part of Jamaican culture. Jamaica lies 18° north of the Equator, a tropical paradise surrounded by the Caribbean Sea where the sun shines perpetually with slight variations in photoperiod throughout the year. The island’s biogeography presents ecologically diverse habitats from high elevations to coastal plains, rainforests to dry limestone forests, and expansive freshwater ecosystems. The islanders’ symbolic love for patronizing the cannabis plant through the expression of performing arts from reggae icons like Bob Marley, Peter Tosh, and so many more has situated ganja synonymously with Jamaica. The artisanal production of ganja in Jamaica represents the ingenuity of the cultivators who reside in these various microclimates throughout the island catering to a plethora of different demographics of consumers located in tourist areas on the north coast, rural townships, urban ghettos, and middle- to upper-class communities. The cultivation methods, post-harvest practices, types of genetics, pricing structure, farm sizes, and distribution method present varying disparities in quality dynamics intended for the various local markets. The lush rainforest habitat to the southern, eastern side of the island is one of the rural areas where ganja farmers tend to trek into the hills to cultivate on lands cleared to facilitate maximum sunlight throughout the day. The farmers grow genetics they have replicated in regular seed production for several generations and cultivate directly into the local soil substrate. The intended market is the local townships in the parish. The farming community of Nine Mile, located in the limestone hills of the parish of St. Ann Jamaica, is the birthplace and resting place of reggae superstar Bob Marley. The Bob Marley Mausoleum is situated on the property where Marley spent his formative years as a young boy growing up. The ganja farmers in this community grow an equatorial cultivar that has a long flowering time with the purpose of the collection of charas finger hash, which is primarily marketed to the consistent busloads of tourists who visit Marley’s shrine daily. The community of Slipe is located on the island’s south coast in the Black River Morass, Jamaica’s largest freshwater wetland ecosystem. The ganja farmers of this community use an interesting mode of transportation—canoes—to tend to their plants daily. This community has developed a hydroponic method of cultivation where the peat from the bog is raised above the water table in long snakelike beds, and the ganja plants are cultivated densely. The seeds are germinated near households and transported as hardened seedlings by canoe through tiny channels cleared from the tall sawgrass to traverse the river. The farmers of this community typically get their germplasm from the neighboring parish of Westmoreland. The plants don’t tend to pass 4 feet in height, with seedling to harvest taking place in 10 to 12 weeks. The community of Orange Hill is located on the western tip of Jamaica near the resort town of Negril. The entire parish of Westmoreland is known for some of the best high-grade ganja on the island. Residents from this western parish tend to flaunt the slogan “The best comes from the West.” The community produces strains of ganja well known to the Western world and modern-day palate with terpene profiles of fruity, gassy, and citrus flavors. The plants are grown in plastic pots or fabric bags using supplemental lighting to generate larger biomass during the vegetative growth period. On harvest day, the plants are placed in temperature- and humidity-controlled rooms to facilitate the drying process. The ganja produced in this area is known to supply the resort towns of Negril and Montego Bay, where the tourists tend to pay, on average, a higher price for the commodity. Happy Gate is situated on the foothills of the Blue Mountain near the capital city of Kingston. The ganja farm is located on the steep slopes of the hillside where the warm orange rays of the sunset dip over the western horizon. The plants grown are hybrids of California origin, where supplemental lighting is used to increase biomass production for the short flowering times of these cultivars. Post-harvest rooms here and in Orange Hill are typically equipped with an air conditioning unit and a dehumidifier for drying and curing. This article was originally published in the March 2024 issue of High Times Magazine.

https://hightimes.com/

Denver Begins Psychedelic Training For First Responders

The Multidisciplinary Association for Psychedelic Studies (MAPS), a 34-year-old nonprofit research and educational organization “that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana,” announced in a press release on Monday that it “has partnered with the City and County of Denver to provide comprehensive training on psychedelic crisis assessment and intervention to the city’s first responders.”  The Psychedelic Crisis Assessment and Intervention training was “commissioned by the Denver Psilocybin Mushroom Policy Review Panel (DPMPRP), a first-of-its-kind panel that was formed after the passage of Ordinance 301 in May 2019, which effectively decriminalized the personal use and possession of psilocybin mushrooms in Denver,” MAPS said in a statement.  Per the press release, the training will cover topics including: “The history, usage, psychological and physiological response, and potential adverse effects of psilocybin ingestion”; “The legal considerations and implications of decriminalization and the role of first responders”; “The standards and protocols for effective psilocybin or psychedelic-related crisis response planning, training, and deployment”; and “The best practices and techniques for assessing, de-escalating, and managing psychedelic crises.” According to the local publication Westworld,  the training program “became even more important in 2022, when Colorado became the second state (after Oregon) to legalize medical psilocybin use and the first state to decriminalize specific psychedelics, including psilocybin, DMT, ibogaine and mescaline.” “Created as part of the 2019 voter initiative decriminalizing psilocybin, the Denver Psilocybin Mushroom Policy Review Panel took a brief hiatus in 2023 after Prop 122 passed,” Westworld reported this week. “But the panel is meeting again and is expected to take a leading position in Denver’s approach to its medical psilocybin rules.” After Prop 122 passed in 2022, Colorado Gov. Jared Polis, a Democrat, signed the measure into law last year. The law directs “the department of revenue [to create] the natural medicine division for the purpose of regulating and licensing the cultivation, manufacturing, testing, storage, distribution, transport, transfer, and dispensation of natural medicine or natural medicine product between natural medicine licensees.” The measure requires the natural medicine division to: “Regulate natural medicine, natural medicine product, and natural medicine businesses, including healing centers, cultivators, manufacturers, and testers, and issue licenses for such businesses; Promulgate rules necessary for the regulation of natural medicine, natural medicine product, and natural medicine businesses; and Perform duties necessary for the regulation of natural medicine, natural medicine product, and natural medicine businesses, including investigatory and disciplinary authority.” Kevin Matthews, former President of the Denver Psilocybin Mushroom Policy Review Panel, celebrated the launch of the training program. “I’m proud of my hometown for stepping into a national leadership role with this training. It represents a giant leap forward for public health and safety with psilocybin and natural medicines in Denver and is a perfect example of what cities can do to better integrate emerging psychedelic policies into their existing infrastructures. I’m looking forward to the city continuing its collaboration with MAPS to monitor outcomes and educate Denver residents on this exciting new issue,” Matthews said in a statement. Sara Gael, a former MAPS Harm Reduction Officer, said the group is “honored and excited to collaborate with the City and County of Denver to provide this groundbreaking training program on psychedelic crisis assessment and intervention.” “We believe that this program will equip first responders with the necessary knowledge and skills to handle psilocybin and psychedelic related crises in a safe and compassionate manner and ultimately improve the health and well-being of the community. This program is also a testament to the progressive and visionary leadership of Denver, which has taken a bold step to decriminalize psilocybin and create a model for other cities to follow,” Gael said. MAPS said in the press release on Monday that its “training aims to enhance the knowledge, attitudes, and skills of first responders to quickly recognize and effectively respond to emotional and behavioral crisis incidents involving psilocybin and other psychedelics.” The group also said that the “Denver Harm Reduction training initiative has been well received by the City of Denver leadership, who recognize the importance and value of providing first responders with the necessary tools and skills to handle psychedelic-related crises in a safe and compassionate manner.” “The program also seeks to enhance responder safety and reduce risk and liability in situations where individuals are experiencing a psychedelic-induced crisis,” the group explained. “After three years, a team of over 20 MAPS and subcontracted professionals with backgrounds in law, medicine, psychiatry, mental health, neuropsychopharmacology, law enforcement, crisis response, quality improvement, and education developed the curriculum. The final training is customized for law enforcement, mental health, and emergency medical service personnel and will be delivered through asynchronous videos and corresponding assessments.”

https://hightimes.com/

Kamala Harris To Host White House Weed Policy Reform Summit With Fat Joe

Vice President Kamala Harris is hosting a White House meeting to discuss drug policy reform that will feature guests including hip hop artist Fat Joe and others who have benefitted from the cannabis pardons granted by the Biden administration. The Friday meeting will also include Kentucky Governor Andy Beshear, a leading proponent of cannabis legalization in his state, and other advocates for ending the criminal prohibition of marijuana.  In October 2022, President Joseph Biden issued an executive order pardoning thousands of people with federal convictions for marijuana possession, saying, “No one should be in jail just for using or possessing marijuana.” In December 2023, the president went further by expanding the pool of people eligible for a pardon for marijuana convictions under federal or Washington, D.C. law.  “President Biden and I have been clear: We must continue to change our nation’s approach to marijuana and reform the criminal justice system,” the vice president said in a statement in December. As I have declared many times before, no one should be in prison simply for smoking weed. That is why we continue to call on Governors to join us in this long-overdue work.” Friday’s meeting at the West Wing of the White House to discuss the Biden administration’s cannabis policy reforms will include guests such as Beshear and five-time Grammy award nominee Fat Joe, who is one of thousands of people to be pardoned by the president.  “Friday’s engagement will build on the Vice President’s efforts to uplift the historic actions the Biden-Harris Administration has taken to ensure everyone has access to opportunity, including by making the criminal justice system more just. This will continue in the weeks and months to come,” a White House official said, according to a report from NBC News. Another pardon recipient, cannabis activist Chris Goldstein, a regional coordinator with the National Organization for the Reform of Marijuana Laws (NORML), will also attend. In 2014, he was convicted of a federal marijuana possession charge for smoking marijuana during a protest in an outdoor area of Independence Hall National Historic Park in Philadelphia.  “These Presidential pardons are a powerful and meaningful action,” Goldstein said in a statement from NORML. “They carry a tremendous power of goodwill — not just to those of us who received them, but for the entire country. These pardons are seen by people everywhere as tangible signs of the White House taking action on marijuana policy.” Goldstein said that he plans to use the time with Harris at Friday’s meeting to bring further awareness to the presidential pardon process. He also hopes to stress the need for further federal action on cannabis reform, including the descheduling of marijuana under the Controlled Substances Act. “Three of us will discuss the real-world impact of our federal marijuana convictions and the relief provided by these Presidential pardons,” said Goldstein. “Thousands of people are still eligible, and this event should help raise awareness for more people to apply.” “We will help represent tens of millions of Americans who have been arrested for marijuana in nearly a century of prohibition,” he added. The news of this week’s White House roundtable discussion on cannabis policy reform was welcomed by justice advocates and members of the cannabis industry. Sarah Gersten, executive director and general counsel at the Last Prisoner Project, a nonprofit working to secure the release of all cannabis prisoners, said that she hopes the meeting results in action from the president. “Clearly, the administration understands that taking action to repair the harms of cannabis criminalization will help energize voters who overwhelmingly believe marijuana should be legal,” Gersten said in a statement on Wednesday. “But the general public also believes no one should be incarcerated for cannabis, and Biden has failed to keep that campaign promise. Biden could free the over 3,000 federal cannabis prisoners with the stroke of a pen. If he truly wants to tout his actions on cannabis reform, bolder action needs to be taken.” Jeffrey M. Zucker, co-founder and president of Denver-based cannabis consultants firm Green Lion Partners, also called for the Biden administration to make meaningful progress on federal cannabis reform. “From this meeting, I hope to see a shift toward comprehensive drug law reform that acknowledges the disproportionate impact of current policies on communities of color,” Zucker said in a statement to High Times. “Reforms prioritizing social justice, harm reduction and economic empowerment would reflect genuine progress.”

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.